Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorpheniramine plus fentanyl versus chlorpheniramine plus ketamine for bronchoscopy sedation
IRCT20140409017198N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of chlorpheniramine, fentanyl and ketamine in None (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Patient satisfaction with bronchoscopy. Started Jun 2018; status: completed.
02
Drugs
chlorpheniraminefentanylketamine
Beyond the preview
Go deeper on IRCT20140409017198N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140409017198N2.